Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Aug;71(2):193–199. doi: 10.1136/jnnp.71.2.193

Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia

R Hilker 1, M Schischniaschvili 1, M Ghaemi 1, A Jacobs 1, J Rudolf 1
PMCID: PMC1737507  PMID: 11459891

Abstract

OBJECTIVES—The advent of botulinum neurotoxin type A (BoNT/A) gave rise to substantial progress in the treatment of focal dystonias. In the light of the high costs of the toxin and the necessity to establish valid outcome indices for this treatment apart from sheer reduction of dystonic muscle tone and posture, the impact of focal dystonia and its treatment with BoNT/A on patients' health related quality of life (HRQL) was determined.
METHODS—Fifty patients with cranial and cervical dystonia treated long term with BoNT/A were enrolled in a prospective, open labelled cohort study. The HRQL was assessed using the EuroQol (EQ-5D) and the short form 36 health survey questionnaire (SF-36) at baseline before BoNT/A injections and at two follow up visits after 6 and 12 weeks covering one BoNT/A treatment period with maximum effect size at the first follow up.
RESULTS—Compared with a general population sample, a considerable negative impact of focal dystonia on HRQL was found in patients under investigation. In both disease types, BoNT/A treatment led to a significant improvement in several HRQL dimensions, in particular providing moderate to marked effect sizes in the fields of mental health and pain. The impairment of HRQL due to pain as well as the BoNT/A induced improvement within this SF-36 subscore were significantly higher in patients with cervical dystonia. Under BoNT/A therapy, no correlation was found between changes of clinical outcome scores and HRQL measures.
CONCLUSIONS—The data confirm that BoNT/A is able to induce a significant, but temporary amelioration of several aspects of HRQL in both types of focal dystonia. This may substantially contribute to the patients' subjective benefit from the therapy. Moreover, the data provide further arguments to accept high costs of the BoNT/A treatment in these severely handicapped patients, as a consequence of its considerable benefit on quality of life.



Full Text

The Full Text of this article is available as a PDF (163.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brans J. W., Lindeboom R., Aramideh M., Speelman J. D. Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia. Neurology. 1998 May;50(5):1461–1463. doi: 10.1212/wnl.50.5.1461. [DOI] [PubMed] [Google Scholar]
  2. Brooks R. EuroQol: the current state of play. Health Policy. 1996 Jul;37(1):53–72. doi: 10.1016/0168-8510(96)00822-6. [DOI] [PubMed] [Google Scholar]
  3. Chan J., Brin M. F., Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6(2):119–126. doi: 10.1002/mds.870060206. [DOI] [PubMed] [Google Scholar]
  4. Garratt A. M., Ruta D. A., Abdalla M. I., Buckingham J. K., Russell I. T. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993 May 29;306(6890):1440–1444. doi: 10.1136/bmj.306.6890.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greene P., Kang U., Fahn S., Brin M., Moskowitz C., Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology. 1990 Aug;40(8):1213–1218. doi: 10.1212/wnl.40.8.1213. [DOI] [PubMed] [Google Scholar]
  6. Gudex C. M., Hawthorne M. R., Butler A. G., Duffey P. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord. 1998 Nov;13(6):941–946. doi: 10.1002/mds.870130613. [DOI] [PubMed] [Google Scholar]
  7. Jahanshahi M., Marsden C. D. Depression in torticollis: a controlled study. Psychol Med. 1988 Nov;18(4):925–933. doi: 10.1017/s0033291700009855. [DOI] [PubMed] [Google Scholar]
  8. Jahanshahi M. Psychosocial factors and depression in torticollis. J Psychosom Res. 1991;35(4-5):493–507. doi: 10.1016/0022-3999(91)90044-o. [DOI] [PubMed] [Google Scholar]
  9. Jankovic J., Brin M. F. Therapeutic uses of botulinum toxin. N Engl J Med. 1991 Apr 25;324(17):1186–1194. doi: 10.1056/NEJM199104253241707. [DOI] [PubMed] [Google Scholar]
  10. Jankovic J., Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987 Apr;37(4):616–623. doi: 10.1212/wnl.37.4.616. [DOI] [PubMed] [Google Scholar]
  11. Jankovic J., Schwartz K. S. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 1993 Apr;43(4):834–836. doi: 10.1212/wnl.43.4.834. [DOI] [PubMed] [Google Scholar]
  12. Jankovic J., Schwartz K., Donovan D. T. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):633–639. doi: 10.1136/jnnp.53.8.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lindeboom R., Brans J. W., Aramideh M., Speelman H. D., De Haan R. J. Treatment of cervical dystonia: a comparison of measures for outcome assessment. Mov Disord. 1998 Jul;13(4):706–712. doi: 10.1002/mds.870130417. [DOI] [PubMed] [Google Scholar]
  14. Odergren T., Tollbäck A., Borg J. Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation. Scand J Rehabil Med. 1994 Dec;26(4):191–195. [PubMed] [Google Scholar]
  15. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord. 1997 Jan;12(1):100–102. doi: 10.1002/mds.870120117. [DOI] [PubMed] [Google Scholar]
  16. Tsui J. K., Eisen A., Stoessl A. J., Calne S., Calne D. B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986 Aug 2;2(8501):245–247. doi: 10.1016/s0140-6736(86)92070-2. [DOI] [PubMed] [Google Scholar]
  17. Van Zandijcke M. Cervical dystonia (spasmodic torticollis). Some aspects of the natural history. Acta Neurol Belg. 1995 Dec;95(4):210–215. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES